Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€173.98
€200.00
-0.86%

Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
buy
Shop Apotheke Europe NV

Start price
Target price
Perf. (%)
€199.00
€250.00
-1.81%

Fair valuation
Known brand
Growths faster than the competition
Revenue growth >5% per year expected
buy
NVIDIA Corp.

Start price
Target price
Perf. (%)
€452.50
€500.00
0.35%

Small cyclical dependencies
Could be worthwhile Investment >10% per year
Growths faster than the competition
Innovative
buy
NVIDIA Corp.

Start price
Target price
Perf. (%)
€452.50
€500.00
0.35%

Small cyclical dependencies
Could be worthwhile Investment >10% per year
Growths faster than the competition
Innovative
buy
NVIDIA Corp.

Start price
Target price
Perf. (%)
€452.50
€500.00
0.35%

Small cyclical dependencies
Could be worthwhile Investment >10% per year
Growths faster than the competition
Innovative
buy
Esperion Therapeutis.Inc.

Start price
Target price
Perf. (%)
€21.27
€35.00
-

Could be worthwhile Investment >10% per year
buy
InVivo Therapeutics Holdings

Start price
Target price
Perf. (%)
€1.47
€2.00
-9.52%

Could be worthwhile Investment >10% per year
buy
Eldorado Gold Corp.

Start price
Target price
Perf. (%)
€9.20
-
0.54%

EBIT growth > 30% per year expected
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
buy
Varta AG

Start price
Target price
Perf. (%)
€129.90
€140.00
3.39%

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Varta AG

Start price
Target price
Perf. (%)
€129.90
€140.00
3.39%

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Overstock.com

Start price
Target price
Perf. (%)
€55.17
-
5.56%

Revenue growth >5% per year expected
EBIT growth >5% per year expected
buy
Apple Inc.

Start price
Target price
Perf. (%)
€115.50
-
1.82%

Could be very worthwhile Investment >20% year
buy
Apple Inc.

Start price
Target price
Perf. (%)
€115.50
-
1.82%

Could be very worthwhile Investment >20% year
buy
Apple Inc.

Start price
Target price
Perf. (%)
€115.50
-
1.82%

Could be very worthwhile Investment >20% year
buy
Apple Inc.

Start price
Target price
Perf. (%)
€115.50
-
1.82%

Could be very worthwhile Investment >20% year
buy
Inpixon

Start price
Target price
Perf. (%)
€1.37
€2.00
3.65%

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Marin Software

Start price
Target price
Perf. (%)
€1.84
€30.00
-

Could be very worthwhile Investment >20% year
buy
Star Equity Holdings Inc.

Start price
Target price
Perf. (%)
€3.10
€30.00
-

Could be very worthwhile Investment >20% year
buy
Eledon Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€12.62
€100.00
-

Could be very worthwhile Investment >20% year
buy
Advaxis Inc.

Start price
Target price
Perf. (%)
€0.62
€60.00
4.48%

Could be very worthwhile Investment >20% year
buy
Inpixon

Start price
Target price
Perf. (%)
€1.37
€15.00
3.65%

Could be very worthwhile Investment >20% year
buy
Teligent Inc.

Start price
Target price
Perf. (%)
€0.99
€10.00
0.00%

Could be very worthwhile Investment >20% year
buy
Zosano Pharma

Start price
Target price
Perf. (%)
€0.90
€10.00
4.47%

Could be very worthwhile Investment >20% year
buy
InVivo Therapeutics Holdings

Start price
Target price
Perf. (%)
€1.43
€10.00
-6.99%

Could be very worthwhile Investment >20% year
buy
Netflix Inc.

Start price
Target price
Perf. (%)
€467.95
-
0.02%

Could be very worthwhile Investment >20% year
Market Leader or Top 3
Very small cyclical dependencies
Well known brand